U.S. Patent Office Ruled Oculir Patent Invalid Based on Dr. Marc Abreu’s Technology for Diabetes Monitoring — Brain …

U.S. Patent Office Ruled Oculir Patent Invalid Based on Dr. Marc Abreu’s Technology for Diabetes Monitoring — Brain …
HAMDEN, Conn.—-The U.S. Patent and Trademark Office has held that all claims in Oculirs Patent No. 6,958,039 to be invalid as not patentable based on prior art from a patent disclosure by Yale researcher, Dr.